✦ LIBER ✦
Risk of recurrent venous thromboembolism or bleeding in relation to thrombophilic risk factors in patients receiving ximelagatran or placebo for long-term secondary prevention of venous thromboembolism
✍ Scribed by Karin Wåhlander; Henry Eriksson; Torbjörn Lundström; Solveig Billing Clason; Ulrika Wall; Per Nyström; Peter Wessman; Sam Schulman; THRIVE III Investigators
- Book ID
- 108673636
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 391 KB
- Volume
- 133
- Category
- Article
- ISSN
- 0007-1048
No coin nor oath required. For personal study only.